Can I Take 5-HTP with Low-Dose Naltrexone?
A physician-reviewed breakdown of the 5-HTP and Low-Dose Naltrexone interaction: mechanism, serotonin syndrome risk, dose timing, monitoring, and when to call your prescriber.
Read clinical reviewTopic Hub
30 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 30 of 30 clinical reviews.
A physician-reviewed breakdown of the 5-HTP and Low-Dose Naltrexone interaction: mechanism, serotonin syndrome risk, dose timing, monitoring, and when to call your prescriber.
Read clinical reviewA physician-reviewed guide to combining alpha-lipoic acid (ALA) with low-dose naltrexone (LDN): pharmacokinetic interactions, hypoglycemia risk, thyroid effects, dosing windows, and monitoring protocols.
Read clinical reviewA physician-reviewed guide to the pharmacodynamic and pharmacokinetic interactions between ashwagandha (KSM-66, Sensoril) and compounded low-dose naltrexone (LDN), including cortisol, thyroid, and immune considerations.
Read clinical reviewA clinical review of the berberine and low-dose naltrexone interaction, covering pharmacokinetics, CYP3A4 inhibition, glucose effects, dosing timing, and safety monitoring for patients using both.
Read clinical reviewA clinician-reviewed guide to the caffeine and low-dose naltrexone interaction, covering pharmacokinetics, CYP1A2 metabolism, blood pressure effects, glucose shifts, and practical timing advice.
Read clinical reviewA clinician-reviewed guide on the calcium and low-dose naltrexone interaction: what the evidence shows, whether dose separation is needed, monitoring tips, and who should exercise extra caution.
Read clinical reviewEvidence-based guide to combining CoQ10 supplements with low-dose naltrexone (LDN). Covers interaction risk, pharmacokinetic data, dose-separation advice, and monitoring recommendations.
Read clinical reviewClinical guide to combining creatine supplementation with low-dose naltrexone (LDN). Covers interaction risk, creatinine monitoring pitfalls, dose-separation advice, and what to tell your prescriber.
Read clinical reviewA clinical review of whether folate is safe to take alongside low-dose naltrexone (LDN), covering pharmacokinetic interactions, MTHFR considerations, dosing timing, and monitoring guidance from primary medical literature.
Read clinical reviewA clinician-reviewed guide to the ginseng and low-dose naltrexone interaction, covering pharmacokinetics, blood sugar effects, anticoagulation risk, monitoring protocols, and when to separate doses.
Read clinical reviewA clinician-reviewed guide to combining glutathione supplementation with compounded low-dose naltrexone (LDN). Covers pharmacokinetic interactions, liver detox pathways, dosing windows, and safety monitoring.
Read clinical reviewA clinician-reviewed guide to combining glycine supplements with compounded low-dose naltrexone (LDN). Covers pharmacokinetic interactions, pharmacodynamic overlap, dose timing, monitoring, and when to ask your prescriber.
Read clinical reviewA physician-reviewed guide covering the hepatotoxicity risk, CYP3A4 interactions, and safe-use protocol for combining green tea extract (EGCG) with compounded low-dose naltrexone (LDN).
Read clinical reviewA physician-reviewed guide covering the pharmacokinetic and pharmacodynamic interaction between L-theanine and compounded low-dose naltrexone (LDN), including safety data, dosing windows, and monitoring guidance.
Read clinical reviewA clinician-reviewed guide to combining lion's mane mushroom with compounded low-dose naltrexone (LDN): mechanism of interaction, safety evidence, dosing windows, and monitoring recommendations.
Read clinical reviewA clinician-reviewed guide to combining magnesium supplements with low-dose naltrexone (LDN): pharmacokinetic interactions, timing, dosing, monitoring, and safety evidence for patients with fibromyalgia, autoimmune disease, and chronic inflammation.
Read clinical reviewA physician-reviewed guide to the melatonin and low-dose naltrexone interaction: mechanism, timing, glucose effects, monitoring, and when to call your prescriber.
Read clinical reviewA physician-reviewed guide covering the pharmacokinetic and pharmacodynamic interaction between NAC and low-dose naltrexone (LDN), including dosing, timing, monitoring, and safety evidence.
Read clinical reviewA clinical review of the safety, pharmacology, and monitoring considerations for combining omega-3 fatty acids (EPA/DHA) with low-dose naltrexone (LDN), including interaction type, dose guidance, and what to watch for.
Read clinical reviewA detailed clinical review of the quercetin and low-dose naltrexone interaction, covering CYP3A4 pharmacokinetics, opioid receptor pharmacodynamics, dose-separation strategies, and monitoring guidance.
Read clinical reviewA clinician-reviewed guide to the reishi mushroom and low-dose naltrexone interaction, covering pharmacokinetic and pharmacodynamic mechanisms, safety signals, monitoring recommendations, and practical dosing guidance.
Read clinical reviewA physician-reviewed guide to the pharmacokinetic and pharmacodynamic interaction between resveratrol and low-dose naltrexone (LDN), including CYP3A4 overlap, estrogenic effects, dosing guidance, and monitoring recommendations.
Read clinical reviewA clinical review of the pharmacokinetic and pharmacodynamic interaction between rhodiola rosea and compounded low-dose naltrexone (LDN), with dosing guidance, monitoring tips, and safety data from primary literature.
Read clinical reviewA physician-reviewed guide covering the pharmacokinetic and pharmacodynamic interactions between saw palmetto and compounded low-dose naltrexone (LDN), including safety, monitoring, and dosing guidance.
Read clinical reviewSt. John's Wort is a potent CYP3A4 inducer that may reduce naltrexone and 6-beta-naltrexol plasma levels, potentially weakening the anti-inflammatory and immunomodulatory effects of Low-Dose Naltrexone. Learn the mechanism, risks, and what to do if you are already taking both.
Read clinical reviewA clinician-reviewed guide covering the pharmacokinetic and pharmacodynamic interactions between turmeric/curcumin and low-dose naltrexone, including safety data, monitoring guidance, and dosing considerations.
Read clinical reviewA physician-reviewed guide covering the safety, mechanism, and practical co-administration of vitamin B12 with compounded low-dose naltrexone (LDN), including monitoring guidance and dosing considerations.
Read clinical reviewA physician-reviewed guide covering the pharmacokinetic and pharmacodynamic interaction between vitamin B6 and compounded low-dose naltrexone, safe dosing ranges, monitoring guidance, and when to contact your prescriber.
Read clinical reviewA clinician-reviewed guide to taking vitamin D alongside low-dose naltrexone (LDN): interaction mechanisms, safety evidence, dosing strategies, and monitoring recommendations.
Read clinical reviewA physician-reviewed guide to the zinc and low-dose naltrexone interaction: pharmacokinetics, immune effects, copper balance, dosing windows, and monitoring.
Read clinical review